X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Abbott India with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ACTAVIS (US) - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   ACTAVIS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
ACTAVIS
Dec-18
ABBOTT INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs6,11013,493-   
Low Rs3,9969,051-   
Sales per share (Unadj.) Rs1,552.23,309.8-  
Earnings per share (Unadj.) Rs188.8-1,066.1-  
Cash flow per share (Unadj.) Rs196.4348.8-  
Dividends per share (Unadj.) Rs55.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs796.613,651.2-  
Shares outstanding (eoy) m21.25332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.33.4 95.6%   
Avg P/E ratio x26.8-10.6 -253.1%  
P/CF ratio (eoy) x25.732.3 79.6%  
Price / Book Value ratio x6.30.8 768.2%  
Dividend payout %29.10-   
Avg Mkt Cap Rs m107,3763,749,019 2.9%   
No. of employees `0003.316.9 19.7%   
Total wages/salary Rs m3,9370-   
Avg. sales/employee Rs Th9,929.365,137.7 15.2%   
Avg. wages/employee Rs Th1,185.10-   
Avg. net profit/employee Rs Th1,207.7-20,980.9 -5.8%   
INCOME DATA
Net Sales Rs m32,9851,100,828 3.0%  
Other income Rs m1,17021,051 5.6%   
Total revenues Rs m34,1551,121,879 3.0%   
Gross profit Rs m5,24528,847 18.2%  
Depreciation Rs m162470,580 0.0%   
Interest Rs m3863,524 0.1%   
Profit before tax Rs m6,215-484,205 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0123,492 0.0%   
Tax Rs m2,203-6,136 -35.9%   
Profit after tax Rs m4,012-354,577 -1.1%  
Gross profit margin %15.92.6 606.8%  
Effective tax rate %35.41.3 2,796.8%   
Net profit margin %12.2-32.2 -37.8%  
BALANCE SHEET DATA
Current assets Rs m22,655451,502 5.0%   
Current liabilities Rs m6,681399,413 1.7%   
Net working cap to sales %48.44.7 1,023.5%  
Current ratio x3.41.1 300.0%  
Inventory Days Days6520 330.8%  
Debtors Days Days2966 44.0%  
Net fixed assets Rs m835124,608 0.7%   
Share capital Rs m2130-   
"Free" reserves Rs m16,7150-   
Net worth Rs m16,9284,540,399 0.4%   
Long term debt Rs m01,598,839 0.0%   
Total assets Rs m24,1627,097,677 0.3%  
Interest coverage x163.7-6.6 -2,471.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.40.2 880.2%   
Return on assets %16.8-4.1 -408.8%  
Return on equity %23.7-7.8 -303.5%  
Return on capital %36.9-4.8 -763.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,4380-   
CASH FLOW
From Operations Rs m1,527393,284 0.4%  
From Investments Rs m-2,148216,058 -1.0%  
From Financial Activity Rs m-1,024-674,993 0.2%  
Net Cashflow Rs m-1,646-65,323 2.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 69.73 Rs / USD

Compare ABBOTT INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ABBOTT INDIA With: DR. DATSONS LABS  SUVEN LIFESCIENCES  PANACEA BIOTECH  VENUS REMEDIES  BIOCON   



Today's Market

Jet Airways and Yes Bank - What's Next for these Beaten Down Stocks?(Podcast)

Jet Airways and Yes Bank, both once market darlings are now being shunned by market participants. The National Stock Exchange (NSE) exchange notified that the shares of the airline.

Related Views On News

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Best 4 Small-cap Stocks to Buy(The 5 Minute Wrapup)

Jun 3, 2019

In the sometimes good sometimes bad market of small caps, there are strong buying opportunities available today. But this great opportunity won't last forever.

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Top 7 Stocks to Profit from Modi's Repeat Performance(Profit Hunter)

Jun 3, 2019

The long-term India story looks promising with the Modi government back in power. Which stocks are likely to go up the most?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 14, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ORCHID PHARMA LTD COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS